Stockscreener 앱 받기
2.93
2.32%
-0.06
전일 마감가:
$2.99
열려 있는:
$3
하루 거래량:
181.86K
Relative Volume:
0.71
시가총액:
$98.90M
수익:
-
순이익/손실:
$-86.60M
주가수익비율:
-1.0345
EPS:
-2.8324
순현금흐름:
$-67.37M
1주 성능:
-24.92%
1개월 성능:
-48.58%
6개월 성능:
-74.45%
1년 성능:
-80.67%
1일 변동 폭
$2.85
$3.3838
1주일 범위
$2.85
$3.91
52주 변동 폭
$2.85
$19.50
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
명칭
Lexeo Therapeutics Inc
전화
(212) 547-9879
주소
345 PARK AVENUE SOUTH, NEW YORK
LXEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
2.92 | 98.90M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.10 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.20 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.39 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.81 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
270.94 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-13 | 개시 | Robert W. Baird | Outperform |
| 2024-06-06 | 개시 | H.C. Wainwright | Buy |
| 2023-11-28 | 개시 | Chardan Capital Markets | Buy |
| 2023-11-28 | 개시 | JP Morgan | Overweight |
| 2023-11-28 | 개시 | Leerink Partners | Outperform |
| 2023-11-28 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-28 | 개시 | Stifel | Buy |
모두보기
Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스
Lexeo stock hits 52-week low at $4.23 amid market challenges - MSN
Lexeo stock plunges to 52-week low at $3.42 amid market challenges By Investing.com - Investing.com South Africa
Lexeo stock plunges to 52-week low at $3.42 amid market challenges - Investing.com India
Lexeo Therapeutics CEO sells $19,090 in stock By Investing.com - Investing.com Nigeria
Lexeo Therapeutics chief medical officer sells $10,410 in stock By Investing.com - Investing.com Canada
Top Executives at Lexeo Therapeutics Cash In on Stock Sales! - TipRanks
Lexeo Therapeutics chief medical officer sells $10,410 in stock - Investing.com
Lexeo Therapeutics CEO sells $19,090 in stock - Investing.com India
Lexeo Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Lexeo Therapeutics CMO Sells Shares to Cover Tax Obligations - TradingView
SG Americas Securities LLC Makes New $72,000 Investment in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $23.80 Consensus Price Target from Brokerages - MarketBeat
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of “Buy” from Brokerages - Defense World
Market Recap: Lexeo Therapeutics Inc (LXEO)’s Negative Momentum, Closing at 4.95 - The Dwinnex
Lexeo Therapeutics Inc (LXEO) Stock: A Look at the Analyst Recommendations - The News Heater
BlackRock, Inc. Expands Holdings with Lexeo Therapeutics Inc. Ac - GuruFocus.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
JPMorgan Chase & Co. Boosts Holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
(LXEO) Trading Advice - Stock Traders Daily
Lexeo stock touches 52-week low at $4.76 amid market challenges - MSN
Leerink Partnrs Has Positive Outlook of LXEO FY2026 Earnings - Defense World
FY2026 EPS Estimate for Lexeo Therapeutics Raised by Analyst - MarketBeat
Lexeo Therapeutics’ (LXEO) Outperform Rating Reiterated at Royal Bank of Canada - Defense World
Royal Bank of Canada Reiterates Outperform Rating for Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat
Barclays PLC Acquires 31,057 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $23.80 Consensus Target Price from Analysts - MarketBeat
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Lexeo stock plunges to 52-week low, hits $5.75 amid market challenges - Investing.com Nigeria
How to Take Advantage of moves in (LXEO) - Stock Traders Daily
Jane Street Group LLC Buys 8,918 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Solid Biosciences stock jumps 11% post-market on FDA update - MSN
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Lexeo Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Increases Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Geode Capital Management LLC Acquires 256,635 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat
Barclays PLC Buys 31,057 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stake Raised by State Street Corp - Defense World
When (LXEO) Moves Investors should Listen - Stock Traders Daily
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
BNP Paribas Financial Markets Increases Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics Inc (LXEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lexeo Therapeutics Inc 주식 (LXEO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| See Tai Sandi | Chief Development Officer |
Feb 19 '25 |
Sale |
4.41 |
1,486 |
6,558 |
53,889 |
| Adler Eric | Chief Medical Officer |
Feb 19 '25 |
Sale |
4.41 |
2,359 |
10,410 |
68,266 |
| Robertson Jenny | Chief Legal Officer |
Feb 19 '25 |
Sale |
4.41 |
2,101 |
9,272 |
57,899 |
2.09%
0.69%
자본화:
|
볼륨(24시간):